Lu Li Selected Research

Small Interfering RNA (siRNA)

10/2021	SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats.
11/2019	Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery.
9/2019	SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
6/2013	[Study on the effect of Klotho gene interferred by plasmid-mediated short hairpin RNA (shRNA) on sinoatrial node pacing channel gene].
1/2012	The importance of GLUT3 for de novo lipogenesis in hypoxia-induced lipid loading of human macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lu Li Research Topics

Disease

226	Neoplasms (Cancer) 06/2024 - 11/2003
73	Inflammation (Inflammations) 05/2024 - 09/2013
54	Infections 04/2024 - 02/2002
31	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2003
30	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2010
30	COVID-19 01/2024 - 01/2020
29	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 09/2010
29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2002
24	Hypoxia (Hypoxemia) 03/2024 - 09/2008
22	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2016
22	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2002
19	Hemorrhage 04/2024 - 02/2012
18	Fibrosis (Cirrhosis) 06/2024 - 07/2013
17	Periodontitis 04/2024 - 06/2012
16	Sepsis (Septicemia) 05/2024 - 01/2018
14	Body Weight (Weight, Body) 04/2024 - 07/2013
14	Type 2 Diabetes Mellitus (MODY) 04/2024 - 04/2008
14	Ischemia 03/2024 - 09/2008
14	Pain (Aches) 01/2023 - 05/2013
12	Carcinogenesis 11/2023 - 02/2002
11	Critical Illness (Critically Ill) 04/2024 - 01/2020
11	Prostatic Neoplasms (Prostate Cancer) 07/2023 - 06/2008
11	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2004
11	Schizophrenia (Dementia Praecox) 01/2023 - 12/2015
10	Obesity 04/2024 - 01/2015
10	Wounds and Injuries (Trauma) 04/2024 - 07/2018
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 01/2018
10	Carcinoma (Carcinomatosis) 01/2023 - 07/2014
10	Hyperuricemia 01/2023 - 04/2015
10	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2015
9	Dysbiosis 03/2024 - 02/2019
9	Edema (Dropsy) 01/2024 - 04/2011
9	Insulin Resistance 01/2024 - 10/2009
9	Necrosis 12/2023 - 04/2011
9	Liver Neoplasms (Liver Cancer) 01/2023 - 05/2011
9	Multiple Myeloma 01/2023 - 06/2012
9	Hypertension (High Blood Pressure) 12/2022 - 07/2013
9	Myocardial Infarction 09/2021 - 04/2014
9	Diarrhea 07/2021 - 08/2004
8	Lung Injury 04/2024 - 01/2015
8	Ischemic Stroke 03/2024 - 01/2014
8	Nasopharyngeal Carcinoma 01/2024 - 01/2015
8	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 12/2014
8	Adenocarcinoma of Lung 07/2023 - 03/2017
7	Pneumonia (Pneumonitis) 01/2024 - 05/2020
7	Heart Failure 01/2024 - 10/2014
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2023 - 07/2017

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2007
51	Biomarkers (Surrogate Marker)IBA 06/2024 - 10/2010
28	LipidsIBA 04/2024 - 01/2012
25	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2008
25	Messenger RNA (mRNA)IBA 04/2024 - 01/2003
24	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2014
21	RNA (Ribonucleic Acid)IBA 03/2024 - 03/2010
19	VaccinesIBA 04/2024 - 06/2014
16	Antiviral Agents (Antivirals)IBA 04/2024 - 05/2014
15	Long Noncoding RNAIBA 05/2024 - 01/2018
14	CytokinesIBA 03/2024 - 06/2011
14	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 03/2010
13	Therapeutic UsesIBA 03/2024 - 05/2012
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 06/2011
12	AntigensIBA 05/2024 - 06/2012
12	Peptides (Polypeptides)IBA 04/2024 - 05/2012
11	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
11	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 10/2002
11	AntioxidantsIBA 12/2023 - 08/2009
11	Transcription Factors (Transcription Factor)IBA 12/2023 - 09/2008
10	CollagenIBA 06/2024 - 12/2014
10	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 09/2013
9	Interleukin-6 (Interleukin 6)IBA 04/2024 - 02/2002
9	EnzymesIBA 11/2023 - 08/2009
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 09/2008
9	CreatinineIBA 01/2023 - 11/2015
9	Oxygen (Dioxygen)IBA 01/2023 - 09/2008
9	CholesterolIBA 10/2022 - 01/2012
8	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 12/2010
8	Hormones (Hormone)IBA 04/2024 - 01/2020
8	InflammasomesIBA 04/2024 - 01/2020
8	Circular RNAIBA 01/2023 - 01/2019
8	CateninsIBA 01/2023 - 12/2010
8	Triglycerides (Triacylglycerol)IBA 10/2022 - 01/2012
8	AntibodiesIBA 01/2022 - 02/2016
8	Circulating Tumor DNAIBA 01/2021 - 01/2016
8	carbopol 940 (sodium polyacrylate)IBA 01/2021 - 03/2015
7	HydrogelsIBA 05/2024 - 01/2021
7	IronIBA 05/2024 - 01/2018
7	LigandsIBA 02/2024 - 11/2009
7	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 11/2011
7	Uric Acid (Urate)IBA 10/2023 - 01/2021

Therapy/Procedure

141	Therapeutics 04/2024 - 07/2005
47	Drug Therapy (Chemotherapy) 04/2024 - 02/2003
28	Immunotherapy 05/2024 - 06/2012
14	Radiotherapy 04/2024 - 08/2004
13	Aftercare (After-Treatment) 02/2023 - 01/2011
10	Photothermal Therapy 02/2024 - 11/2015
10	Precision Medicine 01/2023 - 03/2015
9	Lasers (Laser) 01/2023 - 01/2015
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 12/2019
7	Chemoradiotherapy 01/2024 - 06/2010
7	Continuous Renal Replacement Therapy 10/2023 - 01/2019